UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical pharmacokinetics, ISSN 0312-5963, 1/2011, Volume 50, Issue 1, pp. 25 - 39
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Drug-interactions | Ribavirin, drug interactions | Antiepileptic-drugs, drug interactions | Simvastatin, drug interactions | Voriconazole, drug interactions | Dexamethasone, drug interactions | Fibric-acid-derivatives, drug interactions | Rifampicin, drug interactions | Opioid-analgesics, drug interactions | Antidepressants, drug interactions | Atorvastatin, drug interactions | Antiretrovirals, drug interactions | Anti-infectives, drug interactions | Histamine-H2-receptor-antagonists, drug interactions | Diazepam, drug interactions | Ketoconazole, drug interactions | Fluconazole, drug interactions | Hypericum, drug interactions | HMG-CoA-reductase-inhibitors, drug interactions | Oral-contraceptives, drug interactions | Sildenafil, drug interactions | Omeprazole, drug interactions | Buprenorphine, drug interactions | Rosuvastatin, drug interactions | Non-nucleoside-reverse-transcriptase-inhibitors, drug interactions | Type-5-cyclic-nucleotide- phosphodiesterase-inhibitors, drug interactions | Corticosteroids, drug interactions | Paroxetine, drug interactions | Fluoxetine, drug interactions | Rifapentine, drug interactions | Ethinylestradiolnorethisterone, drug interactions | Ranitidine, drug interactions | Etravirine, drug interactions | Antifungals, drug interactions | Digoxin, drug interactions | Warfarin, drug interactions | Methadone, drug interactions | Fluvastatin, drug interactions | Rifabutin, drug interactions | Sertraline, drug interactions | Azithromycin, drug interactions | Pharmacokinetics | Calcineurin-inhibitors, drug interactions | Itraconazole, drug interactions | Proton-pump-inhibitors, drug interactions | Clarithromycin, drug interactions | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions | Reverse Transcriptase Inhibitors - adverse effects | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Drug-Related Side Effects and Adverse Reactions | Humans | Pyridazines - pharmacokinetics | Drug Therapy, Combination | Pyridazines - adverse effects | Etravirine | Drug interactions | Physiological aspects | Dosage and administration | Research | Properties | Drug therapy | HIV infection | Index Medicus
Journal Article
Pharmacogenomics, ISSN 1462-2416, 05/2017, Volume 18, Issue 7, pp. 701 - 739
drug-drug interaction (DDI) | CYP2C9 | drug-metabolizing enzyme | CYP2C19 | CYP2D6 | drug-drug-gene interaction (DDGI) | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Cytochrome P-450 CYP2D6 - genetics | Pharmacogenetics - methods | Pharmacogenetics - trends | Animals | Drug Interactions - genetics | Humans | Cytochrome P-450 CYP2C19 - genetics | Cytochrome P-450 CYP2D6 - metabolism | Cytochrome P-450 CYP2C19 - metabolism | Inactivation, Metabolic - genetics | Cytochrome P-450 CYP2C9 - metabolism | Cytochrome P-450 CYP2C9 - genetics
Journal Article
Pharmaceutical research, ISSN 0724-8741, 7/2012, Volume 29, Issue 7, pp. 1960 - 1976
Biomedical Engineering | Biochemistry, general | Biomedicine | kinase inhibitors | time-dependent CYP inhibition | Pharmacy | prediction | Medical Law | reactive metabolites | Pharmacology/Toxicology | drug-drug interaction | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Pharmaceutical technology. Pharmaceutical industry | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Cytochrome P-450 Enzyme Inhibitors | Area Under Curve | Humans | Cytochrome P-450 Enzyme System - metabolism | Antineoplastic Agents - chemistry | Blood Proteins - metabolism | Neoplasms - drug therapy | Antineoplastic Agents - metabolism | Protein Kinase Inhibitors - chemistry | Drug Interactions | Microsomes, Liver - drug effects | Models, Biological | Antineoplastic Agents - pharmacology | Microsomes, Liver - enzymology | Protein Kinase Inhibitors - pharmacology | Protein Kinase Inhibitors - metabolism | Drugs | Physiological aspects | Enzymes | Metabolites | Drug interactions | Cytochrome P-450 | Drug therapy | Oncology | Index Medicus
Journal Article
European journal of clinical pharmacology, ISSN 0031-6970, 07/2017, Volume 73, Issue 7, pp. 875 - 882
Drug–drug interaction screening systems | Adverse drug reactions | Potential drug–drug interactions | Actual drug–drug interactions | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Drug Interactions | Drug-Related Side Effects and Adverse Reactions - prevention & control | Prospective Studies | Humans | Hospitalization - statistics & numerical data | Female | Male | Aged | Drug Information Services | Tertiary Care Centers - statistics & numerical data | Medicine, Experimental | Medical research | Comparative analysis | Drug interactions | Drugs | Sensitivity analysis | Toxicity | Digitalis | Systems analysis | Medical screening | Patients | Bleeding | Hypotension | Screening | Side effects | Sensitivity | Hyperkalemia | Drug interaction | Internet | Health risk assessment | Index Medicus
Journal Article
5.
Full Text
SFINX - A drug-drug interaction database designed for clinical decision support systems
European journal of clinical pharmacology, ISSN 0031-6970, 06/2009, Volume 65, Issue 6, pp. 627 - 633
Clinical decision support system | Drug-drug interaction database | Drug interactions | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Decision Support Systems, Clinical | Database Management Systems | Drug Interactions | Decision support systems | Prescription writing | Databases | Pharmacists | Pharmacology | Drug therapy | Index Medicus | Medicin och hälsovetenskap
Journal Article
The AAPS journal, ISSN 1550-7416, 7/2013, Volume 15, Issue 3, pp. 629 - 645
Biochemistry, general | Biotechnology | Biomedicine | Pharmacy | drug–drug interaction studies | regulatory guidance | Pharmacology/Toxicology | industry perspective | drug-drug interaction studies | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pharmaceutical Preparations - metabolism | Animals | Pharmaceutical Preparations - standards | European Union | Practice Guidelines as Topic - standards | United States | Humans | United States Food and Drug Administration - standards | Drug Interactions - physiology | United States Food and Drug Administration - legislation & jurisprudence | Physiological aspects | Enzymes | Invisibility | Analysis | Drug interactions | Index Medicus
Journal Article
Basic & clinical pharmacology & toxicology, ISSN 1742-7835, 01/2019, Volume 124, Issue 1, pp. 28 - 31
cannabis | case report | MiniReview | drug‐drug interaction | warfarin | drug-drug interaction | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Marijuana Smoking - adverse effects | Stroke - prevention & control | Humans | Anticoagulants - therapeutic use | Male | Substance-Related Disorders - complications | Warfarin - pharmacology | Warfarin - therapeutic use | International Normalized Ratio | Stroke - blood | Cannabis - chemistry | Stroke - etiology | Cytochrome P-450 CYP2C9 Inhibitors - pharmacology | Drug Interactions | Heart Valve Prosthesis Implantation - adverse effects | Anticoagulants - pharmacology | Adult | Dronabinol - pharmacology | Cytochrome P-450 CYP2C9 - metabolism | Endocarditis - surgery | Cytochrome | Drug abuse | Enzymes | Warfarin | Epilepsy | Cytochrome P450 | Drug interactions | Case reports | Metabolism | Patients | Heart valves | Substrates | Bleeding | Literature reviews | Case studies | Cannabis | Recreational use | Cannabinoids | Marijuana | Drug interaction | Tetrahydrocannabinol | Cytochromes P450 | Index Medicus
Journal Article
The AAPS journal, ISSN 1550-7416, 6/2009, Volume 11, Issue 2, pp. 300 - 306
Biochemistry, general | Biotechnology | Biomedicine | drug–drug interaction | Pharmacy | drug development | prediction | new drug application | Pharmacology/Toxicology | regulatory and guidance | New drug application | Regulatory and guidance | Drug development | Drug-drug interaction | Prediction | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Guidelines as Topic | Pharmaceutical Preparations - metabolism | Animals | Carrier Proteins - metabolism | Drug Interactions | United States | Computer Simulation | Humans | Pharmacokinetics | Forecasting | United States Food and Drug Administration | Physiological aspects | Enzymes | Drug interactions | Analysis | Index Medicus
Journal Article
Frontiers in pharmacology, ISSN 1663-9812, 08/2018, Volume 9, pp. 895 - 895
Journal Article